|Bid||61.00 x 1300|
|Ask||61.28 x 2900|
|Day's range||60.42 - 61.65|
|52-week range||45.32 - 68.34|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||N/A|
|Earnings date||29 Oct 2020 - 02 Nov 2020|
|Forward dividend & yield||1.80 (2.93%)|
|Ex-dividend date||02 Jul 2020|
|1y target est||71.75|
Opdivo Plus Yervoy Demonstrates Durable Survival Benefit vs. Chemotherapy in Patients with Previously Untreated Malignant Pleural Mesothelioma
Stocks ended higher Thursday as investors digested better-than-expected weekly jobs data, and eyed another set of corporate earnings results and more developments around stimulus talks in Washington. The Nasdaq Composite closed above 11,000 for the first time ever, and Facebook, Apple and Amazon closed at records.
Bristol Myers (BMY) delivered earnings and revenue surprises of 11.64% and 0.44%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?